['DRUGS WITH CLINICAL RECOMMENDATIONS REGARDING COADMINISTRATION (SEE PRECAUTIONS , DRUG INTERACTIONS )', 'DRUG', 'DIDANOSINE DOSAGE', 'N', 'AUC DIDANOSINE (95% CI)', 'CMAX OF DIDANOSINE (95% CI)', 'ALLOPURINOL , RENALLY IMPAIRED, 300 MG/DAY', '200 MG SINGLE DOSE', '2', '\xe2\x86\x91312%', '\xe2\x86\x91232%', 'HEALTHY VOLUNTEER, 300 MG/DAY FOR 7 DAYS', '400 MG SINGLE DOSE', '14', '\xe2\x86\x91113%', '\xe2\x86\x9169%', 'GANCICLOVIR , 1000 MG Q8H, 2 H AFTER DIDANOSINE', '200 MG Q12H', '12', '\xe2\x86\x91111%', 'NA', 'METHADONE , CHRONIC MAINTENANCE DOSE', '200 MG SINGLE DOSE', '16, 10 A', '\xe2\x86\x9357%', '\xe2\x86\x9366%', 'TENOFOVIR , B 300 MG ONCE DAILY 1 H AFTER DIDANOSINE', '250 C OR 400 MG ONCE DAILY FOR 7 DAYS', '14', '\xe2\x86\x9144% (31, 59%) D', '\xe2\x86\x9428% (11, 48%) D', 'NO CLINICALLY SIGNIFICANT INTERACTIONS OBSERVED', 'CIPROFLOXACIN, 750 MG Q12H FOR 3 DAYS, 2 H BEFORE DIDANOSINE', '200 MG Q12H FOR 3 DAYS', '8 E', '\xe2\x86\x9316%', '\xe2\x86\x9328%', 'ININAVIR, 800 MG SINGLE DOSE SIMULTANEOUS', '200 MG SINGLE DOSE', '16', '\xe2\x86\x94', '\xe2\x86\x94', '1 H BEFORE DIDANOSINE', '200 MG SINGLE DOSE', '16', '\xe2\x86\x9317% (-27, -7%) D', '\xe2\x86\x9313% (-28, 5%) D', 'KETOCONAZOLE, 200 MG/DAY FOR 4 DAYS, 2 H BEFORE DIDANOSINE', '375 MG Q12H FOR 4 DAYS', '12 E', '\xe2\x86\x94', '\xe2\x86\x9312%', 'LOPERAMIDE, 4 MG Q6H FOR 1 DAY', '300 MG SINGLE DOSE', '12 E', '\xe2\x86\x94', '\xe2\x86\x9323%', 'METOCLOPRAMIDE, 10 MG SINGLE DOSE', '300 MG SINGLE DOSE', '12 E', '\xe2\x86\x94', '\xe2\x86\x9113%', 'RANITIDINE, 150 MG 2 H BEFORE DIDANSINE', '375 MG SINGLE DOSE', '12 E', '\xe2\x86\x9114%', '\xe2\x86\x9113%', 'RIFABUTIN, 300 OR 600 MG/DAY FOR 12 DAYS', '167 OR 250 MG Q12H FOR 12 DAYS', '11', '\xe2\x86\x9113% (-1, 27%)', '\xe2\x86\x9117% (-4, 38%)', 'RITONAVIR, 600 MG Q12H FOR 4 DAYS', '200 MG Q12H FOR 4 DAYS', '12', '\xe2\x86\x9313% (0, 23%)', '\xe2\x86\x9316% (5, 26%)', 'STAVUDINE, 40 MG Q12H FOR 4 DAYS', '100 MG Q12H FOR 4 DAYS', '10', '\xe2\x86\x94', '\xe2\x86\x94', 'SULFAMETHOXAZOLE, 1000 MG SINGLE DOSE', '200 MG SINGLE DOSE', '8 E', '\xe2\x86\x94', '\xe2\x86\x94', 'TRIMETHOPRIM, 200 MG SINGLE DOSE', '200 MG SINGLE DOSE', '8 E', '\xe2\x86\x94', '\xe2\x86\x9117% (-23, 77%)', 'ZIDOVUDINE, 200 MG Q7H FOR 3 DAYS', '200 MG Q12H FOR 3 DAYS', '8 E', '\xe2\x86\x94', '\xe2\x86\x94', '\xe2\x86\x91 INDICATES INCREASE \xe2\x86\x93 INDICATES DECREASE \xe2\x86\x94 INDICATES NO CHANGE, OR MEAN INCREASE OR DECREASE OF <10%. A PARELLEL-GROUP DESIGN; ENTRIES ARE SUBJECTS RECEIVING COMBINATION AND CONTROL REGIMENS, RESPECTIVELY. B TENOGOVIR DISOPROXIL FUMARATE C PATIENTS <60 KG WITH CREATININE CLEARANCE >60 ML/MIN. D 90% CI E HIV-INFECTED PATIENTS N/A NOT AVAILABLE']